Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Alterations in Muscle Tone lll

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

First molecular detection of <i>Theileria haneyi</i> infection in horses in Southern Spain.

Frontiers in veterinary science·2026

Same author

Neuroprotective Role of Cannabinoid CB<sub>1</sub> and GPR55 Receptors in a Cell Model of Multiple Sclerosis.

Molecular neurobiology·2026

Same author

Discrete interneuron subsets participate in GluN1/GluN3A excitatory glycine receptor (eGlyR)-mediated regulation of hippocampal network activity throughout development and evolution.

Research square·2025

Same author

Apolipoprotein D Expression Dynamics During Cuprizone-Induced Demyelination and Remyelination in a Mouse Model of Multiple Sclerosis.

International journal of molecular sciences·2025

Same author

True Prevalence and Seroprevalence of Piroplasmosis in Horses in Southwestern Europe.

Animals : an open access journal from MDPI·2025

Same author

Evaluation of Blood Biochemical Parameters and Ratios in Piroplasmosis-Infected Horses in an Endemic Region.

Veterinary sciences·2025

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Brain mitochondrial dysfunction and oxidative damage in Parkinson's disease.

Ana Navarro¹, Alberto Boveris

¹Department of Biochemistry and Molecular Biology, School of Medicine, University of Cádiz, Plaza Fragela, 9, 11003, Cádiz, Spain. ana.navarro@uca.es

Journal of Bioenergetics and Biomembranes

|November 17, 2009

Summary

Parkinson's disease (PD) involves constant mitochondrial dysfunction and oxidative damage, particularly affecting Complex I activity in the brain. This damage contributes to cognitive impairment in PD patients.

More Related Videos

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

Related Experiment Videos

Last Updated: Jun 18, 2026

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

Area of Science:

Neuroscience
Mitochondrial Biology
Neurodegenerative Diseases

Background:

Parkinson's disease (PD) pathogenesis involves complex factors with consistent mitochondrial involvement.
Two key interdependent conditions in PD are brain mitochondrial dysfunction and oxidative damage.

Purpose of the Study:

To elucidate the molecular mechanisms underlying Complex I inactivation in Parkinson's disease.
To investigate the role of mitochondrial dysfunction in the frontal cortex and its contribution to cognitive impairment in PD.

Main Methods:

Analysis of mitochondrial Complex I activity in substantia nigra and frontal cortex of PD patients.
Investigation of molecular reactions contributing to Complex I inactivation, including ONOO(-) mediated reactions, free radical intermediates, and adduction reactions.
Assessment of adaptive responses such as increased mitochondrial nitric oxide synthase (mtNOS) activity, mitochondrial mass, and biogenesis.

Main Results:

Mitochondrial dysfunction and reduced Complex I activity are evident in the substantia nigra and frontal cortex of PD patients.
Complex I inactivation is attributed to ONOO(-) reactions, lipid peroxidation intermediates, and amine-aldehyde adduction.
Inhibitory effects on Complex I synergistically increase O(2)(-) and ONOO(-) production, leading to protein denaturation.
Adaptive responses including increased mtNOS activity, mitochondrial mass, and biogenesis are observed in PD patients.

Conclusions:

Mitochondrial dysfunction in the frontal cortex is a significant factor contributing to cognitive impairment in Parkinson's disease.
Understanding these mitochondrial mechanisms is crucial for developing therapeutic strategies for PD.